Dr. Neena Kapoor, MD
Claim this profileChildren's Hospital Los Angeles
Area of expertise
Aplastic Anemia
Neena Kapoor, MD has run 3 trials for Aplastic Anemia. Some of their research focus areas include:
Acute Lymphoblastic Leukemia
Neena Kapoor, MD has run 3 trials for Acute Lymphoblastic Leukemia. Some of their research focus areas include:
Affiliated Hospitals
Children's Hospital Los Angeles
Children's Hospital Of Los Angeles
Clinical Trials Neena Kapoor, MD is currently running
Tabelecleucel
for Post-Transplant Cancer
The purpose of this study is to determine the clinical benefit and characterize the safety profile of tabelecleucel for the treatment of Epstein-Barr virus-associated post-transplant lymphoproliferative disease (EBV+ PTLD) in the setting of (1) solid organ transplant (SOT) after failure of rituximab (SOT-R) and rituximab plus chemotherapy (SOT-R+C) or (2) allogeneic hematopoietic cell transplant (HCT) after failure of rituximab.
Recruiting
2 awards
Phase 3
12 criteria
T Cell-Depleted Stem Cell Transplant
for Leukemia
This phase II trial studies how well naive T-cell depletion works in preventing chronic graft-versus-host disease in children and young adults with blood cancers undergoing donor stem cell transplant. Sometimes the transplanted white blood cells from a donor attack the body's normal tissues (called graft versus host disease). Removing a particular type of T cell (naive T cells) from the donor cells before the transplant may stop this from happening.
Recruiting
1 award
Phase 2
22 criteria
More about Neena Kapoor, MD
Clinical Trial Related
8 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 7 Active Clinical Trials
Treatments Neena Kapoor, MD has experience with
- Busulfan
- Nomacopan (rVA576)
- Unlicensed Cryopreserved Cord Blood Units
- Donor Search Prognosis Score
- Autologous CD34+ HSC Cells Transduced With The Lentiviral Vector Containing A ShRNA Targeting BCL11a
- Adenovirus-specific Cytotoxic T-lymphocytes
Breakdown of trials Neena Kapoor, MD has run
Aplastic Anemia
Acute Lymphoblastic Leukemia
Sickle Cell Disease
Primary Immunodeficiency
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Neena Kapoor, MD specialize in?
Neena Kapoor, MD focuses on Aplastic Anemia and Acute Lymphoblastic Leukemia. In particular, much of their work with Aplastic Anemia has involved HLA-A positive patients, or patients who are HLA-A negative.
Is Neena Kapoor, MD currently recruiting for clinical trials?
Yes, Neena Kapoor, MD is currently recruiting for 7 clinical trials in Los Angeles California. If you're interested in participating, you should apply.
Are there any treatments that Neena Kapoor, MD has studied deeply?
Yes, Neena Kapoor, MD has studied treatments such as Busulfan, nomacopan (rVA576), Unlicensed Cryopreserved Cord Blood Units.
What is the best way to schedule an appointment with Neena Kapoor, MD?
Apply for one of the trials that Neena Kapoor, MD is conducting.
What is the office address of Neena Kapoor, MD?
The office of Neena Kapoor, MD is located at: Children's Hospital Los Angeles, Los Angeles, California 90027 United States. This is the address for their practice at the Children's Hospital Los Angeles.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.